ArticleRheumatology international2011

HMG-CoA reductase inhibitor simvastatin suppresses Toll-like receptor 2 ligand-induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients.

Haobo Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.